A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity

Abstract Drug development for mood disorders can greatly benefit from the development of robust, reliable, and objective biomarkers. The incorporation of smartphones and wearable devices in clinical trials provide a unique opportunity to monitor behavior in a non-invasive manner. The objective of th...

Full description

Bibliographic Details
Main Authors: Ahnjili Zhuparris, Ghobad Maleki, Liesbeth van Londen, Ingrid Koopmans, Vincent Aalten, Iris E. Yocarini, Vasileios Exadaktylos, Albert van Hemert, Adam Cohen, Pim Gal, Robert-Jan Doll, Geert Jan Groeneveld, Gabriël Jacobs, Wessel Kraaij
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-46075-2
_version_ 1797636904465727488
author Ahnjili Zhuparris
Ghobad Maleki
Liesbeth van Londen
Ingrid Koopmans
Vincent Aalten
Iris E. Yocarini
Vasileios Exadaktylos
Albert van Hemert
Adam Cohen
Pim Gal
Robert-Jan Doll
Geert Jan Groeneveld
Gabriël Jacobs
Wessel Kraaij
author_facet Ahnjili Zhuparris
Ghobad Maleki
Liesbeth van Londen
Ingrid Koopmans
Vincent Aalten
Iris E. Yocarini
Vasileios Exadaktylos
Albert van Hemert
Adam Cohen
Pim Gal
Robert-Jan Doll
Geert Jan Groeneveld
Gabriël Jacobs
Wessel Kraaij
author_sort Ahnjili Zhuparris
collection DOAJ
description Abstract Drug development for mood disorders can greatly benefit from the development of robust, reliable, and objective biomarkers. The incorporation of smartphones and wearable devices in clinical trials provide a unique opportunity to monitor behavior in a non-invasive manner. The objective of this study is to identify the correlations between remotely monitored self-reported assessments and objectively measured activities with depression severity assessments often applied in clinical trials. 30 unipolar depressed patients and 29 age- and gender-matched healthy controls were enrolled in this study. Each participant’s daily physiological, physical, and social activity were monitored using a smartphone-based application (CHDR MORE™) for 3 weeks continuously. Self-reported depression anxiety stress scale-21 (DASS-21) and positive and negative affect schedule (PANAS) were administered via smartphone weekly and daily respectively. The structured interview guide for the Hamilton depression scale and inventory of depressive symptomatology–clinical rated (SIGHD-IDSC) was administered in-clinic weekly. Nested cross-validated linear mixed-effects models were used to identify the correlation between the CHDR MORE™ features with the weekly in-clinic SIGHD-IDSC scores. The SIGHD-IDSC regression model demonstrated an explained variance (R2) of 0.80, and a Root Mean Square Error (RMSE) of ± 15 points. The SIGHD-IDSC total scores were positively correlated with the DASS and mean steps-per-minute, and negatively correlated with the travel duration. Unobtrusive, remotely monitored behavior and self-reported outcomes are correlated with depression severity. While these features cannot replace the SIGHD-IDSC for estimating depression severity, it can serve as a complementary approach for assessing depression and drug effects outside the clinic.
first_indexed 2024-03-11T12:40:46Z
format Article
id doaj.art-7fc77d26e65c4a94b6761c3ca90e1519
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-11T12:40:46Z
publishDate 2023-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-7fc77d26e65c4a94b6761c3ca90e15192023-11-05T12:18:05ZengNature PortfolioScientific Reports2045-23222023-11-0113111410.1038/s41598-023-46075-2A smartphone- and wearable-based biomarker for the estimation of unipolar depression severityAhnjili Zhuparris0Ghobad Maleki1Liesbeth van Londen2Ingrid Koopmans3Vincent Aalten4Iris E. Yocarini5Vasileios Exadaktylos6Albert van Hemert7Adam Cohen8Pim Gal9Robert-Jan Doll10Geert Jan Groeneveld11Gabriël Jacobs12Wessel Kraaij13Centre for Human Drug Research (CHDR)Centre for Human Drug Research (CHDR)Transparant Centre for Mental Health CareCentre for Human Drug Research (CHDR)Centre for Human Drug Research (CHDR)Leiden Institute of Advanced Computer Science (LIACS), Leiden UniversityCentre for Human Drug Research (CHDR)Leiden University Medical Centre (LUMC), Leiden UniversityCentre for Human Drug Research (CHDR)Centre for Human Drug Research (CHDR)Centre for Human Drug Research (CHDR)Centre for Human Drug Research (CHDR)Centre for Human Drug Research (CHDR)Leiden Institute of Advanced Computer Science (LIACS), Leiden UniversityAbstract Drug development for mood disorders can greatly benefit from the development of robust, reliable, and objective biomarkers. The incorporation of smartphones and wearable devices in clinical trials provide a unique opportunity to monitor behavior in a non-invasive manner. The objective of this study is to identify the correlations between remotely monitored self-reported assessments and objectively measured activities with depression severity assessments often applied in clinical trials. 30 unipolar depressed patients and 29 age- and gender-matched healthy controls were enrolled in this study. Each participant’s daily physiological, physical, and social activity were monitored using a smartphone-based application (CHDR MORE™) for 3 weeks continuously. Self-reported depression anxiety stress scale-21 (DASS-21) and positive and negative affect schedule (PANAS) were administered via smartphone weekly and daily respectively. The structured interview guide for the Hamilton depression scale and inventory of depressive symptomatology–clinical rated (SIGHD-IDSC) was administered in-clinic weekly. Nested cross-validated linear mixed-effects models were used to identify the correlation between the CHDR MORE™ features with the weekly in-clinic SIGHD-IDSC scores. The SIGHD-IDSC regression model demonstrated an explained variance (R2) of 0.80, and a Root Mean Square Error (RMSE) of ± 15 points. The SIGHD-IDSC total scores were positively correlated with the DASS and mean steps-per-minute, and negatively correlated with the travel duration. Unobtrusive, remotely monitored behavior and self-reported outcomes are correlated with depression severity. While these features cannot replace the SIGHD-IDSC for estimating depression severity, it can serve as a complementary approach for assessing depression and drug effects outside the clinic.https://doi.org/10.1038/s41598-023-46075-2
spellingShingle Ahnjili Zhuparris
Ghobad Maleki
Liesbeth van Londen
Ingrid Koopmans
Vincent Aalten
Iris E. Yocarini
Vasileios Exadaktylos
Albert van Hemert
Adam Cohen
Pim Gal
Robert-Jan Doll
Geert Jan Groeneveld
Gabriël Jacobs
Wessel Kraaij
A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
Scientific Reports
title A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
title_full A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
title_fullStr A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
title_full_unstemmed A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
title_short A smartphone- and wearable-based biomarker for the estimation of unipolar depression severity
title_sort smartphone and wearable based biomarker for the estimation of unipolar depression severity
url https://doi.org/10.1038/s41598-023-46075-2
work_keys_str_mv AT ahnjilizhuparris asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT ghobadmaleki asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT liesbethvanlonden asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT ingridkoopmans asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT vincentaalten asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT iriseyocarini asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT vasileiosexadaktylos asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT albertvanhemert asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT adamcohen asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT pimgal asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT robertjandoll asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT geertjangroeneveld asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT gabrieljacobs asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT wesselkraaij asmartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT ahnjilizhuparris smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT ghobadmaleki smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT liesbethvanlonden smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT ingridkoopmans smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT vincentaalten smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT iriseyocarini smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT vasileiosexadaktylos smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT albertvanhemert smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT adamcohen smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT pimgal smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT robertjandoll smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT geertjangroeneveld smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT gabrieljacobs smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity
AT wesselkraaij smartphoneandwearablebasedbiomarkerfortheestimationofunipolardepressionseverity